Young & Partners: Recent Episodes
Young & Partners
Young & Partners is an international investment banking firm uniquely dedicated to the chemical and life science industries. The Firm is a licensed broker-dealer and a member of the FINRA and SIPC. It is a highly regarded chemical industry and life sciences investment banking firm that is in its 24th year.
A fireside discussion between Robert Westervelt, Editor in Chief of Chemical Week and Peter Young, CEO of Young & Partners
Peter Young, President & CEO of Young & Partners, on Environmental, Social & Governance pressures, describes the landscape and characterizes the implications for Chemical companies.
Peter Young, CEO and President of Young & Partners, Prakash Chandrasekar, Managing Director & Partner at Boston Consulting Group and Raj Gupta, Chairman of APTIV plc, discuss supply chain challenges facing the Chemical industry.
Young & Partners CEO and President, Peter Young, interviews Ed Breen, Chairman & CEO of DuPont de Nemours, Inc., covering the various company transformations he's lead throughout his career.
Peter Young moderates discussion with Lisa Henderson, Editor-in-Chief of Pharmaceutical Executive, and Michael Shih, Head of Business Development at Biogen.
Young & Partners Managing Director, Randy Guggenheimer, interviews Ali Behbahani, General Partner at New Enterprise Associates, Inc., and Cary Pfeffer, Partner at Third Rock Ventures, LLC. covering the current venture capital landscape in the Life Sciences.
Young & Partners CEO and President, Peter Young, interviews Seifi Ghasemi, CEO of Air Products and Chemicals, Inc., covering his background and career progression.
Young & Partners CEO and President, Peter Young, interviews Bob Patel, CEO of LyondellBasell Industries NV, covering his background and major inflection points during his time with LyondellBasell Industries NV.
Peter Young, President and CEO of Young and Partners, Anla Cheng, CEO of SupChina and Jeremy Goldkorn, Editor-in-Chief of SupChina, discuss the political situation, business environment and China-US relations.
Young & Partners CEO and President, Peter Young, interviews Pierre Brondeau, Chairman of FMC Corporation, covering his background and major inflection points during his time at FMC Corporation.
Jim Fitterling, CEO of Dow Inc., and Raj Gupta, Chairman of Avantor, Inc., discuss how their various organizations are adapting to both short-term and long-term change in their respective industries from the CEO and Board perspective.
Peter Young, CEO and President of Young & Partners, Dr. Stephen Spielberg, Senior Advisor at Young & Partners and Lisa Henderson, Group Content Director of Pharmaceutical Executive, discuss major issues facing the biopharmaceutical industry today.
Dr. Stephen Spielberg, Senior Advisor at Young & Partners, interview Dr. Peter Marks, Director of CBER, FDA, covering modern challenges facing the agency.
Jim Fitterling, CEO of Dow Inc., and Raj Gupta, Chairman of Avantor, Inc., are interviewed by Peter Young, CEO and President of Young & Partners, covering how their various organizations responded to the COVID-19 pandemic and the changing political environment.